News Conference News ESC 2022 Old Drug Acetazolamide Offers New Tricks in Acute HF: ADVOR L.A. McKeown August 27, 2022
News Conference News ESC 2022 EchoNet AI Algorithm Beats Sonographers for Estimating LV Function Shelley Wood August 27, 2022
News Conference News ESC 2022 PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2 Michael O'Riordan August 27, 2022
News Conference News ESC 2022 First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory L.A. McKeown August 26, 2022
News Conference News ESC 2022 Polypill Bests Usual Care in Patients With Recent MI: SECURE Michael O'Riordan August 26, 2022
News Conference News ESC 2022 TIME of Antihypertensive Dose Doesn’t Matter for CV Protection Todd Neale August 26, 2022
News Daily News Enoxaparin Tops Aspirin for Preventing VTE After Hip or Knee Arthroplasty Todd Neale August 25, 2022
News Daily News Higher Annual TAVI Volumes Linked to Greater Use of Embolic Protection L.A. McKeown August 23, 2022
News Daily News New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill Shelley Wood August 23, 2022
News Daily News Antibiotics Before Invasive Dental Work Helpful in High-Risk Patients Caitlin E. Cox August 22, 2022
News Opinion Editor's Corner ESC 2022 What’s Going to Be Hot at ESC 2022? Shelley Wood August 22, 2022
News Daily News Even With Revascularization in ISCHEMIA, Skipping Meds Hurt Health Status Todd Neale August 19, 2022
News Daily News AHA Urges More Home-Based Dialysis in Advanced Kidney Failure Michael O'Riordan August 18, 2022
News Daily News CV Symptoms Deserve More Attention, Quantification: AHA Statement Yael L. Maxwell August 18, 2022
News Daily News US, European Hypertension Guidelines: More Alike Than Different Caitlin E. Cox August 17, 2022
News Daily News After COVID-19, Unvaccinated at Risk for Long-term CVD Complications Michael O'Riordan August 16, 2022
News Daily News Salt Substitutes Could Have BP, CV Benefits Worldwide: Meta-analysis Yael L. Maxwell August 16, 2022
News Features Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD? Michael O'Riordan August 15, 2022